2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neurofibromatosis 1
5
Breast Neoplasms
3
Prostatic Neoplasms
2
Melanoma
2
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Noonan Syndrome
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Leukemia, Myeloid, Acute
1
Learning Disabilities
1
Laryngeal Neoplasms
1
Inhibition, Psychological
1
Hypopharyngeal Neoplasms
1
Dyslexia
1
Cognition Disorders
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Breast Carcinoma In Situ
1
Autism Spectrum Disorder
1
Interventions
Transcranial Direct Current Stimulation
1
Spermine Synthase
1
Radiosurgery
1
Palliative Care
1
Modafinil
1
Methods
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Lovastatin
1
Lomustine
1
Lamotrigine
1
Functional Status
1
Exercise
1
Drug Therapy
1
Donepezil
1
DNA Methylation
1
Cognitive Training
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cognition Disorders
×
Lovastatin
×
Clear all
NCT03504501
2023-11-30
SynCoRAS
Technical University of Munich
Phase 2
Terminated
16 enrolled